| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.075 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |